Lv3
286 积分 2024-03-29 加入
521MO Efficacy of pembrolizumab monotherapy (PM) for advanced clear cell gynaecological cancer (CCGC): Phase II PEACOCC trial
3天前
已完结
Molecular determinants of clinical outcomes of pembrolizumab in recurrent ovarian cancer: Exploratory analysis of KEYNOTE-100
10天前
已完结
ARE CLEAR CELL CARCINOMA AND MUCINOUS CARCINOMA OF THE OVARY SENSITIVE TO COMBINATIN CHEMOTHERAPY WITH PACLITAXEL AND CARBOPLATIN?: A MULTI-INSTITUTE PROSPECTIVE STUDY(GOGO-OV1)
28天前
已关闭
Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016
29天前
已完结
596 A randomised phase II study of nintedanib (BIBF1120) compared to chemotherapy in patients with recurrent clear cell carcinoma of the ovary or endometrium. (NICCC/ENGOT-OV36)
1个月前
已完结
《2021 NCCN卵巢癌包括输卵管癌及原发性腹膜癌临床实践指南（第1版）》解读
1个月前
已完结
Alpelisib for treatment of patients with PIK3CA-related overgrowth spectrum (PROS)
2个月前
已完结
Postrecurrence Treatment in Neoadjuvant or Adjuvant FDA Registration Trials
2个月前
已完结
Ovarian clear cell carcinoma
4个月前
已完结
Ovarian clear cell carcinoma
4个月前
已关闭
Crocus sativus tepals extract suppresses subcutaneous adipose tissue hypertrophy and improves systemic insulin sensitivity in mice on high‐fat diet
4个月前
已采纳
Recalcitrant dermatophyte infections: identification and risk factors
4个月前
已采纳
Pubertal development and premature ovarian insufficiency in patients with APECED
4个月前
已采纳
What Are We Missing? Magnetic Resonance Imaging-negative Clinically Significant Prostate Cancer in PROMIS
4个月前
已采纳
A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER)
4个月前
已采纳
Re: Konrad H. Stopsack. Efficacy of PARP Inhibition in Metastatic Castration-resistant Prostate Cancer is Very Different with Non-BRCA DNA Repair Alterations: Reconstructing Prespecified Endpoints for Cohort B from the Phase 3 PROfound Trial of Olaparib. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.09.024
4个月前
已采纳
皖公网安备34019202002308
